Breast Cancer
SoftScan pilot study shows positive preliminary results for monitoring the treatment of breast cancer
Published in MD Week, June 15th, 2007
ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that the preliminary clinical results from its breast cancer treatment monitoring pilot study conducted at the Sunnybrook Health Sciences Centre using its SoftScan(R) optical imaging device were positive. 'Preliminary results are in line with expectations, suggesting that our SoftScan optical imaging device will be effective at showing early tumor response to breast cancer treatment,' said S'bastien Gignac, President and CEO of ART. "Using SoftScan as a monitoring tool, oncologists...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week
Source: MD Week (2007-06-15)
More Articles from MD Week
- Aging
Researchers Find Deadly Prescription Drug Effects Six Years Before FDA - Arthroplasty
New arthroplasty research reported from Institute for Health - Bravo by Elder Health
Bravo by Elder Health Names Gil Miller Its Executive Vice President of Sales - Breast Cancer
IMRT Allows Higher Radiation Therapy Dose for Breast Cancer - Cancer
VIDEO from Medialink and Siemens: Revolutionary Breakthrough in Breast Cancer Detection - Chemical Warfare
Research Looks to Detect Chemical Warfare Agents - More from this issue of MD Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
